UBS Group’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $678K | Buy |
309,687
+247,456
| +398% | +$542K | ﹤0.01% | 4624 |
|
|
2025
Q1 | $67.2K | Sell |
62,231
-65,590
| -51% | -$70.8K | ﹤0.01% | 6072 |
|
|
2024
Q4 | $133K | Buy |
+127,821
| New | +$133K | ﹤0.01% | 5489 |
|
|
2023
Q4 | – | Sell |
-26
| Closed | -$43 | – | 8508 |
|
|
2023
Q3 | $43 | Buy |
+26
| New | +$43 | ﹤0.01% | 7883 |
|
|
2022
Q4 | – | Sell |
-1,359
| Closed | -$3K | – | 9789 |
|
|
2022
Q3 | $3K | Buy |
+1,359
| New | +$3K | ﹤0.01% | 8468 |
|
|
2019
Q4 | – | Sell |
-2,410
| Closed | -$15K | – | 7168 |
|
|
2019
Q3 | $15K | Buy |
+2,410
| New | +$15K | ﹤0.01% | 5951 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7126 |
|
|
2019
Q1 | – | Sell |
-99
| Closed | -$6K | – | 7091 |
|
|
2018
Q4 | $6K | Buy |
+99
| New | +$6K | ﹤0.01% | 6561 |
|
|
2018
Q3 | – | Sell |
-35
| Closed | -$6K | – | 7162 |
|
|
2018
Q2 | $6K | Buy |
35
+24
| +218% | +$4.11K | ﹤0.01% | 6489 |
|
|
2018
Q1 | $2K | Sell |
11
-6
| -35% | -$1.09K | ﹤0.01% | 6650 |
|
|
2017
Q4 | $7K | Buy |
17
+11
| +183% | +$4.53K | ﹤0.01% | 6265 |
|
|
2017
Q3 | $3K | Buy |
+6
| New | +$3K | ﹤0.01% | 6478 |
|
|
2017
Q2 | – | Sell |
-15
| Closed | -$14K | – | 6838 |
|
|
2017
Q1 | $14K | Buy |
15
+14
| +1,400% | +$13.1K | ﹤0.01% | 5484 |
|
|
2016
Q4 | $3K | Buy |
+1
| New | +$3K | ﹤0.01% | 6439 |
|